Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …

The diagnosis of Alzheimer's disease can be improved by the use of biological measures.
Biomarkers of functional impairment, neuronal loss, and protein deposition that can be …

BACKGROUND: In the earliest clinical stages of Alzheimer’s disease (AD) when symptoms
are mild, clinical diagnosis can be difficult. AD pathology most likely precedes symptoms. …

Alzheimer's disease (AD) is a fast growing world-wide epidemic. AD is a genetically complex,
slowly progressive, and irreversible neurodegenerative disease of the brain. During …

Hyperphosphorylated tau protein (P-tau) in CSF is a core biomarker candidate of Alzheimer's
disease. Hyperphosphorylation of tau is thought to lead to neurofibrillary changes, a …

Alzheimer's disease (AD) is characterized by a heterogeneous distribution of pathological
changes throughout the brain. Magnetic resonance imaging can be used to investigate the …

Subjects with mild cognitive impairment (MCI) have an increased risk to develop Alzheimer's
disease (AD). Voxel-based MRI studies have demonstrated that widely distributed cortical …

Objectives: To estimate a regional progression pattern of amyloid deposition from cross-sectional
amyloid-sensitive PET data and evaluate its potential for in vivo staging of an …

Alzheimer's disease is characterized by the degeneration and loss of cholinergic neurones
in the nucleus basalis Meynert, located within the substantia innominata at the ventral …

Alzheimer's disease is a progressive neurodegenerative disease that typically manifests
clinically as an isolated amnestic deficit that progresses to a characteristic dementia syndrome. …